Hydration Pharmaceuticals Company (ASX: HPC), known as Hydralyte USA, has announced it will raise up to $1.25 million through ...
Hosted on MSN1mon
Prestige Consumer Healthcare anticipates FY2025 EPS of $4.5 backed by debt reduction initiativesEarnings per share rose to $1.22, reflecting a 15% growth. Strong international growth, notably from the Hydralyte brand, and product performance in North America, such as Summer's Eve and Clear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback